Pricing Log in Create free account

Quince Therapeutics, Inc. (IRLA) vs LianBio Sponsored ADR (LIANY)

Quince Therapeutics, Inc. and LianBio Sponsored ADR are both Biotechnology companies. Quince Therapeutics, Inc. and LianBio Sponsored ADR are of similar size ($34.2M and $33.8M). Quince Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; LianBio Sponsored ADR trades at 0.0×. Across the 8 metrics below, LianBio Sponsored ADR leads on 5 and Quince Therapeutics, Inc. on 3.

Valuation

Metric IRLA LIANY Biotechnology median
P/E n/m 0.02 8.50
P/S n/m n/m 9.71
P/B n/m 0.01 2.13
Price to free cash flow n/m 0.02 20.82
EV/EBITDA n/m 5.72 0.64
EV/Sales n/m n/m 9.21
Earnings yield (442.37%) 5,773.40% (33.15%)
Free cash flow yield (23.96%) 4,795.89% (25.50%)

Profitability

Metric IRLA LIANY Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 784.09% 70.96% (56.36%)
Return on assets (76.68%) 66.19% (48.04%)
Return on invested capital 0.00% (450.47%) 0.00%

Growth

Metric IRLA LIANY Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (28.24%) 75.44% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IRLA LIANY Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 14.52 17.03 4.72
Net debt to EBITDA 0.00 7.41 0.96

Dividend

Metric IRLA LIANY Biotechnology median
Dividend yield — 0.00% 0.09%
Payout ratio — — —

Size

Metric IRLA LIANY Biotechnology median
Market cap 33.79m 34.19m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack